| Dr Kenneth Cerreta, MD | |
|
430 Morton Plant St Ste 405, Clearwater, FL 33756-3394 | |
| (727) 443-0611 | |
| (727) 461-5493 |
| Full Name | Dr Kenneth Cerreta |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 13 Years |
| Location | 430 Morton Plant St Ste 405, Clearwater, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093004160 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | ME131027 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morton Plant Hospital | Clearwater, FL | Hospital |
| Mease Dunedin Hospital | Dunedin, FL | Hospital |
| Morton Plant Mease Healthcare Countryside | Safety harbor, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bay Area Chest Physicians P A | 0941299010 | 13 |
| Baycare Medical Group, Inc. | 6406753623 | 959 |
News Archive
On June 21-23, 2011, the New York Academy of Sciences will bring together physicians, neurologists, clinical neuropsychologists, cellular and molecular biologists and patient advocates to discuss current challenges and potential solutions for improving diagnosis, treatment and management of the cognitive symptoms of MS.
The Africa Progress Panel on Tuesday in Berlin called on the Group of Eight industrialized nations to fulfill commitments made at its 2005 summit regarding aid to Africa, including HIV/AIDS funding, the Washington Post reports (Williams, Washington Post , 4/25).
GOP presidential hopeful Mitt Romney's health policies are not only the target of his Republican opponents but are also drawing attention and barbs from Democrats. Also on the trail, Newt Gingrich, another GOP primary candidate, criticized the tenor of the campaign season so far.
Surfix B.V., together with its shareholders Qurin Diagnostics B.V. and LioniX International B.V., already successfully developing bio-photonic nanochips for cancer detection and other applications, today announces an accelerated development plan to allow mass-scale COVID-19 diagnosis and immunity detection with the financial support and in close collaboration with PhotonDelta.
Oramed Pharmaceuticals Inc., a developer of alternative drug delivery systems, announced today that the paper entitled, "Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects," authored by Dr. Roy Eldor, Dr. Miriam Kidron and Dr. Ehud Arbit, was accepted and published in the Diabetes, Obesity and Metabolism journal.
› Verified 9 days ago
| Entity Name | Baycare Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043269871 PECOS PAC ID: 6406753623 Enrollment ID: O20031216000718 |
News Archive
On June 21-23, 2011, the New York Academy of Sciences will bring together physicians, neurologists, clinical neuropsychologists, cellular and molecular biologists and patient advocates to discuss current challenges and potential solutions for improving diagnosis, treatment and management of the cognitive symptoms of MS.
The Africa Progress Panel on Tuesday in Berlin called on the Group of Eight industrialized nations to fulfill commitments made at its 2005 summit regarding aid to Africa, including HIV/AIDS funding, the Washington Post reports (Williams, Washington Post , 4/25).
GOP presidential hopeful Mitt Romney's health policies are not only the target of his Republican opponents but are also drawing attention and barbs from Democrats. Also on the trail, Newt Gingrich, another GOP primary candidate, criticized the tenor of the campaign season so far.
Surfix B.V., together with its shareholders Qurin Diagnostics B.V. and LioniX International B.V., already successfully developing bio-photonic nanochips for cancer detection and other applications, today announces an accelerated development plan to allow mass-scale COVID-19 diagnosis and immunity detection with the financial support and in close collaboration with PhotonDelta.
Oramed Pharmaceuticals Inc., a developer of alternative drug delivery systems, announced today that the paper entitled, "Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects," authored by Dr. Roy Eldor, Dr. Miriam Kidron and Dr. Ehud Arbit, was accepted and published in the Diabetes, Obesity and Metabolism journal.
› Verified 9 days ago
| Entity Name | Bay Area Chest Physicians P A |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972584829 PECOS PAC ID: 0941299010 Enrollment ID: O20040512000671 |
News Archive
On June 21-23, 2011, the New York Academy of Sciences will bring together physicians, neurologists, clinical neuropsychologists, cellular and molecular biologists and patient advocates to discuss current challenges and potential solutions for improving diagnosis, treatment and management of the cognitive symptoms of MS.
The Africa Progress Panel on Tuesday in Berlin called on the Group of Eight industrialized nations to fulfill commitments made at its 2005 summit regarding aid to Africa, including HIV/AIDS funding, the Washington Post reports (Williams, Washington Post , 4/25).
GOP presidential hopeful Mitt Romney's health policies are not only the target of his Republican opponents but are also drawing attention and barbs from Democrats. Also on the trail, Newt Gingrich, another GOP primary candidate, criticized the tenor of the campaign season so far.
Surfix B.V., together with its shareholders Qurin Diagnostics B.V. and LioniX International B.V., already successfully developing bio-photonic nanochips for cancer detection and other applications, today announces an accelerated development plan to allow mass-scale COVID-19 diagnosis and immunity detection with the financial support and in close collaboration with PhotonDelta.
Oramed Pharmaceuticals Inc., a developer of alternative drug delivery systems, announced today that the paper entitled, "Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects," authored by Dr. Roy Eldor, Dr. Miriam Kidron and Dr. Ehud Arbit, was accepted and published in the Diabetes, Obesity and Metabolism journal.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth Cerreta, MD 430 Morton Plant St Ste 405, Clearwater, FL 33756-3394 Ph: (727) 443-0611 | Dr Kenneth Cerreta, MD 430 Morton Plant St Ste 405, Clearwater, FL 33756-3394 Ph: (727) 443-0611 |
News Archive
On June 21-23, 2011, the New York Academy of Sciences will bring together physicians, neurologists, clinical neuropsychologists, cellular and molecular biologists and patient advocates to discuss current challenges and potential solutions for improving diagnosis, treatment and management of the cognitive symptoms of MS.
The Africa Progress Panel on Tuesday in Berlin called on the Group of Eight industrialized nations to fulfill commitments made at its 2005 summit regarding aid to Africa, including HIV/AIDS funding, the Washington Post reports (Williams, Washington Post , 4/25).
GOP presidential hopeful Mitt Romney's health policies are not only the target of his Republican opponents but are also drawing attention and barbs from Democrats. Also on the trail, Newt Gingrich, another GOP primary candidate, criticized the tenor of the campaign season so far.
Surfix B.V., together with its shareholders Qurin Diagnostics B.V. and LioniX International B.V., already successfully developing bio-photonic nanochips for cancer detection and other applications, today announces an accelerated development plan to allow mass-scale COVID-19 diagnosis and immunity detection with the financial support and in close collaboration with PhotonDelta.
Oramed Pharmaceuticals Inc., a developer of alternative drug delivery systems, announced today that the paper entitled, "Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects," authored by Dr. Roy Eldor, Dr. Miriam Kidron and Dr. Ehud Arbit, was accepted and published in the Diabetes, Obesity and Metabolism journal.
› Verified 9 days ago
Dr. David Scott Borislow, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 508 Jeffords St Ste D, Clearwater, FL 33756 Phone: 727-443-7700 Fax: 737-461-4379 | |
Dr. Irma Alves, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 300 Pinellas St, Clearwater, FL 33756 Phone: 727-462-7908 Fax: 727-462-7904 | |
Dr. Mark Alan Whiting, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 400 Pinellas St, Suite 350, Clearwater, FL 33756 Phone: 727-462-3696 Fax: 813-635-2637 | |
Dr. Steven Charles Bowman, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3251 N Mcmullen Booth Rd, Suite 303, Clearwater, FL 33761 Phone: 727-725-6110 Fax: 727-669-9742 | |
Dr. Mahesh Amin, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 455 Pinellas St Ste 330, Clearwater, FL 33756 Phone: 727-724-8611 Fax: 727-724-0425 | |
Dr. Sara Enid Cruz-luna, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1243 S Myrtle Ave, Clearwater, FL 33756 Phone: 727-442-3126 Fax: 727-287-4559 | |
Neisa I Diaz, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 13501 Icot Blvd Ste 114, Clearwater, FL 33760 Phone: 727-754-7880 Fax: 727-754-7885 |